Searched for
NORTH AMERICA GENERICS REVENUE
America's 250th birthday is fast becoming Trump's showAs America approaches its 250th birthday, the celebration is overshadowed by Donald Trump's pervasive presence, from proposed currency appe...- US Stocks: Nike shares fall on grim sales outlook; China woes hit turnaround plansShares of Nike fell as investors raised alarms over the slow pace of recovery with CEO Elliott Hill at the helm for nearly two years. While...
- Nike Q4 FY2026: Earnings surprise, China woes and the path aheadNike reported stronger-than-expected quarterly revenue and earnings, supported by improving demand in North America and a recovery in its w...
- Rs 19 lakh crore shocker! TCS, Infosys & 2 IT giants crash 50% from peak: Is the absolute worst yet to come?India's top IT firms, including TCS and Infosys, have seen their market value plummet by at least 50% from peak levels, erasing nearly Rs 1...
- Catch 'em before they fall: India's new climate safety netIndian cities face a dual threat of extreme heat and torrential monsoons, severely impacting informal workers. Traditional insurance and go...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- Indian Americans across Texas celebrate 250 years of US independenceIndian-American communities across Texas marked America's 250th independence anniversary with vibrant celebrations in Houston and Dallas-Fo...
- Auto ancillary sector revenue grew 12.5% in FY26 on volume gains and improved product mix: ReportIndian auto ancillaries witnessed robust revenue growth of 12.5% in FY26, driven by strong volumes and a better product mix. While EBITDA a...
- Persistent Systems to acquire Nagarro; combined entity to generate $2.9 billion in annualised revenueIndian IT firm Persistent Systems is making a significant move by launching a takeover bid for German digital engineering company Nagarro S...
- Enhance experience with ads, not ruin itThe integrity of football is at risk with FIFA's introduction of hydration breaks, which double as advertising opportunities. Players and c...
- Omnicom Media claims top spot in global media billings after IPG integrationOmnicom Media has become the world's largest media management network, boasting $75.6 billion in global billings after integrating with IPG...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- "Purely a sporting matter": FIFA President Infantino defends WC2026 hydration breaksFIFA President Gianni Infantino has defended the new three-minute hydration breaks at the World Cup 2026, emphasizing their purely sporting...
- American scientists and ranchers are racing to stop a flesh-eating fly after 15 animal cases turned up in Texas and New Mexico, and the battle could take more than a yearFlesh-eating maggots, the New World screwworm, have reappeared in Texas and New Mexico, infecting livestock and at least one dog. Driven by...
- More trees do not always mean more birds, and a Japanese study found grassland species fell by over 70% near shelterbelts, showing that restoring habitat can sometimes reduce biodiversityA surprising study reveals that planting trees as windbreaks on farms can devastate bird populations, particularly those needing open grass...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- JLR projects revenue growth and return to profit in FY27, doubles down on USJaguar Land Rover anticipates a strong comeback in financial year 2027. The company projects a 13% revenue increase and a return to profita...
- Tata Motors PV shares plunge 10% after weaker than expected JLR FY27 guidanceTata Motors Passenger Vehicles shares dropped significantly. This followed Jaguar Land Rover's investor day where its financial outlook for...
Load More
